Those who served are more likely than the general public to die by suicide, but an alternative treatment holds promise.

The treatment can cost up to $30,000 but for eligible patients, will soon be covered by one of Australia’s leading private ...

A comprehensive peer-reviewed invited review published today in Psychedelics by Dr. Kenji Hashimoto and colleagues (Dr.

If California bans Veterans Guardian and companies like them, many veterans will be left with no allies to navigate a system ...

Physicians are exploring psychedelic-assisted therapy for patients — but federal law still forbids it. A healthcare attorney ...

A clinical LSD formulation shows promise for severe anxiety. Trials reveal meaningful symptom relief and limited side effects. Generalized anxiety disorder affects about one in every twenty adults in ...

Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point they rarely leave their home and are unable to work and build meaningful ...

A peer-reviewed viewpoint article published today in Psychedelics by Prof. Xiaohui Wang and colleagues examines the therapeutic potential of psychedelic substances for treating stress-related ...

Emyria Ltd ( ($AU:EMD) ) just unveiled an announcement. Emyria Limited has announced a significant expansion of its services with a new funding ...

Legalizing psilocybin potentially is taking a step forward, as New York State lawmakers, on both sides of the aisle, are ...

Mental health has shown concerning trends globally in recent years, posing major challenges for clinical care in child, adolescent, and young adult ...